Vadivarhe Speciality Chemicals Ltd
₹ 45.0
-3.23%
27 Nov
10:54 a.m.
About
Incorporated in 2009, Vadivarhe Speciality Chemicals Ltd is in the business of manufacturing Specialty Chemicals, Intermediates & API
Key Points
- Market Cap ₹ 57.5 Cr.
- Current Price ₹ 45.0
- High / Low ₹ 75.4 / 27.4
- Stock P/E 113
- Book Value ₹ 2.49
- Dividend Yield 0.00 %
- ROCE 10.2 %
- ROE 1.24 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 18.7 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -4.69%
- The company has delivered a poor sales growth of 4.37% over past five years.
- Company has a low return on equity of -40.2% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13.16 | 13.87 | 19.03 | 26.28 | 35.03 | 25.56 | 32.36 | 28.58 | 26.47 | 21.45 | 43.68 | 40.08 | 40.45 | |
15.41 | 11.18 | 11.52 | 18.89 | 24.64 | 21.80 | 29.97 | 37.82 | 27.01 | 28.24 | 40.22 | 35.48 | 37.45 | |
Operating Profit | -2.25 | 2.69 | 7.51 | 7.39 | 10.39 | 3.76 | 2.39 | -9.24 | -0.54 | -6.79 | 3.46 | 4.60 | 3.00 |
OPM % | -17.10% | 19.39% | 39.46% | 28.12% | 29.66% | 14.71% | 7.39% | -32.33% | -2.04% | -31.66% | 7.92% | 11.48% | 7.42% |
0.05 | 0.11 | 0.11 | 0.14 | 1.05 | 0.45 | 0.40 | 0.37 | 1.08 | 0.66 | 1.09 | 0.47 | 0.41 | |
Interest | 1.10 | 1.02 | 0.89 | 1.21 | 0.85 | 0.77 | 1.11 | 1.37 | 1.32 | 1.69 | 1.61 | 1.83 | 1.15 |
Depreciation | 1.69 | 1.65 | 1.09 | 1.36 | 1.14 | 1.27 | 1.63 | 1.75 | 1.81 | 1.79 | 1.79 | 1.74 | 1.75 |
Profit before tax | -4.99 | 0.13 | 5.64 | 4.96 | 9.45 | 2.17 | 0.05 | -11.99 | -2.59 | -9.61 | 1.15 | 1.50 | 0.51 |
Tax % | -32.06% | 46.15% | 29.61% | 13.51% | 36.51% | 18.43% | -20.00% | -17.93% | 6.56% | -0.00% | -0.00% | 96.67% | |
-3.39 | 0.07 | 3.98 | 4.29 | 6.01 | 1.77 | 0.06 | -9.84 | -2.76 | -9.61 | 1.15 | 0.06 | 0.51 | |
EPS in Rs | -70.07 | 1.45 | 82.27 | 88.67 | 4.97 | 1.38 | 0.05 | -7.70 | -2.16 | -7.52 | 0.90 | 0.05 | 0.40 |
Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 4% |
3 Years: | 15% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | 1% |
5 Years: | -8% |
3 Years: | 26% |
TTM: | 116% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 14% |
1 Year: | 26% |
Return on Equity | |
---|---|
10 Years: | -4% |
5 Years: | -37% |
3 Years: | -40% |
Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.84 | 4.84 | 4.84 | 4.84 | 12.09 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 |
Reserves | 5.66 | 5.73 | 9.68 | 12.62 | 11.38 | 14.64 | 14.70 | 4.87 | 2.11 | -7.50 | -6.36 | -6.29 | -9.60 |
16.77 | 14.35 | 11.24 | 10.65 | 12.74 | 9.66 | 20.98 | 19.67 | 23.45 | 24.42 | 26.94 | 26.18 | 31.36 | |
4.26 | 7.75 | 3.67 | 5.09 | 9.52 | 7.13 | 9.28 | 14.00 | 8.84 | 11.97 | 13.08 | 8.94 | 6.40 | |
Total Liabilities | 31.53 | 32.67 | 29.43 | 33.20 | 45.73 | 44.21 | 57.74 | 51.32 | 47.18 | 41.67 | 46.44 | 41.61 | 40.94 |
17.79 | 15.93 | 15.02 | 13.96 | 17.12 | 19.68 | 26.09 | 25.20 | 25.98 | 24.32 | 23.36 | 21.59 | 21.89 | |
CWIP | -0.00 | -0.00 | -0.00 | -0.00 | 0.09 | 1.58 | 1.88 | 2.81 | 0.33 | 1.09 | 0.99 | 1.56 | 1.58 |
Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
13.69 | 16.69 | 14.36 | 19.19 | 28.47 | 22.90 | 29.72 | 23.26 | 20.82 | 16.21 | 22.04 | 18.41 | 17.42 | |
Total Assets | 31.53 | 32.67 | 29.43 | 33.20 | 45.73 | 44.21 | 57.74 | 51.32 | 47.18 | 41.67 | 46.44 | 41.61 | 40.94 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.83 | 6.41 | 5.27 | 3.18 | 2.09 | 7.15 | -1.22 | 4.10 | -0.28 | 1.24 | -0.35 | 2.26 | |
-1.03 | -0.00 | -0.18 | -0.64 | -4.33 | -5.32 | -8.27 | -1.68 | 0.02 | -0.82 | -0.69 | -0.51 | |
3.87 | -6.19 | -4.01 | -3.43 | 1.88 | -1.12 | 9.25 | -2.34 | 0.58 | -0.60 | 1.05 | -2.04 | |
Net Cash Flow | 0.02 | 0.22 | 1.07 | -0.89 | -0.37 | 0.70 | -0.23 | 0.08 | 0.32 | -0.18 | -0.00 | -0.29 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 71.56 | 135.00 | 70.97 | 117.50 | 159.63 | 122.95 | 143.25 | 104.34 | 125.62 | 34.37 | 48.22 | 44.99 |
Inventory Days | 188.83 | 223.98 | 221.86 | 116.68 | 61.66 | 170.63 | 221.62 | 122.32 | 77.40 | 168.42 | 120.82 | 147.37 |
Days Payable | 146.00 | 128.58 | 50.10 | 108.01 | 115.85 | 120.38 | 174.61 | 205.42 | 152.95 | 218.56 | 145.63 | 122.81 |
Cash Conversion Cycle | 114.38 | 230.40 | 242.73 | 126.18 | 105.44 | 173.20 | 190.26 | 21.24 | 50.07 | -15.76 | 23.40 | 69.55 |
Working Capital Days | 85.70 | 76.84 | 102.23 | 86.67 | 140.56 | 143.80 | 155.66 | 61.30 | 76.25 | 37.95 | 56.07 | 81.96 |
ROCE % | -14.79% | 4.41% | 25.77% | 22.61% | 29.66% | 7.86% | 2.88% | -25.06% | -5.34% | -24.02% | 7.61% | 10.15% |
Documents
Announcements
-
Disclosure under SEBI Takeover Regulations
25 November 2024 - Mrs. Meena Sunil Pophale has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the SEBI (Substantial Acquisition of Shares and …
-
Outcome of Board Meeting
14 November 2024 - Vadivarhe Speciality Chemicals Limited has informed regarding Outcome of Board meeting held on November 14, 2024 for approval of Unaudited Half-yearly Financial Results of Quarter …
-
Financial Result Updates
14 November 2024 - Vadivarhe Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Board Meeting Intimation
5 November 2024 - VADIVARHE SPECIALITY CHEMICALS LIMITED has informed about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the …
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 October 2024 - Vadivarhe Speciality Chemicals Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended September 30, 2024
Business Overview:[1][2]
Company manufactures Active Pharmaceutical Ingredients, bulk drugs, special chemicals, Organic Chemicals, Inorganic Chemicals, Bio-Chemicals and Drug Intermediaries. Raw materials are procured primarily from local market and imported from China. Further, finished products of VSCL are sold locally and
also exported to the countries viz, UK,
USA, Switzerland and Malaysia. Company's manufacturing unit is located at Nashik
with an installed capacity of 150 MTPA